Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

BS B2B Bureau  |  Mumbai 

Lupin receives US FDA nod for sleep disorder drug armodafinil

The US Food and Drug Administration (FDA) has granted its final approval for Ltd’s tablet (in strengthens of 50 mg, 150 mg, 200 mg and 250 mg), which is used for treating sleep disorder. The company had filed the application for the new drug from its Goa manufacturing facility.

The company’s US subsidiary Pharmaceuticals Inc is expected to commence promotion of this approved product, a version of Inc’s tablet, in the US shortly. 

are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy or shift work disorder (SWD). tablet had US sales of $ 515.6 million, according to MAT September 2016.

RECOMMENDED FOR YOU

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million
The US Food and Drug Administration (FDA) has granted its final approval for Ltd’s tablet (in strengthens of 50 mg, 150 mg, 200 mg and 250 mg), which is used for treating sleep disorder. The company had filed the application for the new drug from its Goa manufacturing facility.

The company’s US subsidiary Pharmaceuticals Inc is expected to commence promotion of this approved product, a version of Inc’s tablet, in the US shortly. 

are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy or shift work disorder (SWD). tablet had US sales of $ 515.6 million, according to MAT September 2016.

image
Business Standard
177 22

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

The US Food and Drug Administration (FDA) has granted its final approval for Ltd’s tablet (in strengthens of 50 mg, 150 mg, 200 mg and 250 mg), which is used for treating sleep disorder. The company had filed the application for the new drug from its Goa manufacturing facility.

The company’s US subsidiary Pharmaceuticals Inc is expected to commence promotion of this approved product, a version of Inc’s tablet, in the US shortly. 

are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy or shift work disorder (SWD). tablet had US sales of $ 515.6 million, according to MAT September 2016.

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard